Athena Global Investors’s Pfizer PFE Stock Holding History

Athena Global Investors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$1.21M	Sell	37,295 -5,541	-13%	-$175K	3.63%	11
2016 Q4	$1.32M	Hold	42,836	–	–	3.21%	12
2016 Q3	$1.38M	Sell	42,836 -22,514	-34%	-$753K	3.58%	11
2016 Q2	$2.18M	Sell	65,350 -32,352	-33%	-$1.03M	3.36%	13
2016 Q1	$2.75M	Hold	97,702	–	–	2.83%	15
2015 Q4	$2.99M	Hold	97,702	–	–	2.87%	15
2015 Q3	$2.91M	Hold	97,702	–	–	2.96%	15
2015 Q2	$3.11M	Sell	97,702 -43,870	-31%	-$1.43M	2.8%	14
2015 Q1	$4.67M	Sell	141,572 -1,301	-0.9%	-$41.4K	3.31%	13
2014 Q4	$4.22M	Sell	142,873 -141,267	-50%	-$4.05M	2.89%	17
2014 Q3	$7.97M	Hold	284,140	–	–	3.64%	13
2014 Q2	$8M	Buy	284,140 +61,655	+28%	+$1.76M	3.56%	14
2014 Q1	$6.78M	Buy	+222,485	New	+$6.63M	4.09%	11

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Athena Global Investors's PFE Position: Q1 2017 in Review

Athena Global Investors reduced its Pfizer (PFE) stake by 13% in Q1 2017, selling an estimated $175K and leaving 37,295 shares worth $1.21M. The position accounts for 3.63% of the portfolio, ranked #11.

Athena Global Investors first reported a position in PFE in Q1 2014 and has held it in 13 quarters since. The position peaked at $8M in Q2 2014. 2,075 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

Athena Global Investors held 37,295 shares of Pfizer worth $1.21M as of Q1 2017.
Athena Global Investors sold 5,541 Pfizer shares in Q1 2017, an estimated $175K.
Pfizer made up 3.63% of Athena Global Investors's portfolio in Q1 2017, its #11 holding.
Athena Global Investors first reported a position in Pfizer in Q1 2014 and has held it in 13 quarters since.
Athena Global Investors's Pfizer position peaked at $8M in Q2 2014.
2,075 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Athena Global Investors's 13F filing for Q1 2017, filed 16 May 2017.